Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01326260 · ClinicalTrials.gov registry record
Early Aggressive Correction of Severe Acidosis With Tris-hydroxymethylaminomethane (THAM)
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 60
- Enrollment target
NCT01326260 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 60 participants.
The verdict
NCT01326260 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study involved the medical record review of resuscitation records for all severely-injured trauma patients requiring emergent surgical intervention and significant acidosis from 2005 through 2009.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01326260
The ClinicalTrials.gov registry entry for NCT01326260 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01326260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01326260 about?
NCT01326260 is a clinical study titled "Early Aggressive Correction of Severe Acidosis With Tris-hydroxymethylaminomethane (THAM)". This study involved the medical record review of resuscitation records for all severely-injured trauma patients requiring emergent surgical intervention and significant acidosis from 2005 through 2009.
What is the current status of trial NCT01326260?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2010-07. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT01326260?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.